| Members |
targetComponentId |
| Partial avulsion of nail |
Partial excision of nail and nail matrix |
| Partial avulsion of tooth |
Extrusive luxation of tooth |
| Partial division of tendon of muscle of eye OS |
Partial division of tendon of muscle of eye |
| Partial excision of femur |
ostectomie partielle d'un fémur |
| Partial excision of pituitary gland by unspecified approach |
Partial hypophysectomy |
| Partial hysterectomy |
hystérectomie subtotale par voie abdominale (intervention) |
| Partial hysterectomy |
hystérectomie subtotale par voie abdominale (intervention) |
| Partial thickness skin graft (substance) |
Split thickness graft of skin (substance) |
| Partner had vasectomy |
Partner had vasectomy (situation) |
| Partner had vasectomy |
Partner had vasectomy (situation) |
| Parturient paresis |
faiblesse musculaire |
| Passing no clots vaginally |
Passing no clots vaginally |
| Passive exercises of patient |
Musculoskeletal exercise, passive |
| Passive manipulation (procedure) |
Passive movement (observable entity) |
| Passive smoking risk |
At risk from passive smoking |
| Past pointing |
Past pointing (finding) |
| Pasteurella anatipestifer (organism) |
Riemerella anatipestifer |
| Pasteurella anatis |
Gallibacterium anatis |
| Pasteurella avium |
Avibacterium avium |
| Pasteurella gallinarum |
Avibacterium gallinarum (organism) |
| Pasteurella granulomatis |
Mannheimia granulomatis |
| Pasteurella haemolytica |
Mannheimia haemolytica |
| Pasteurella trehalosi |
Bibersteinia trehalosi (organism) |
| Pasteurella volantium |
Avibacterium volantium (organism) |
| Patch (morphologic abnormality) |
Plaque |
| Patellar ligament reconstruction |
action : réparation |
| Pathological alcohol intoxication |
Psychotic behaviour caused by ethanol |
| Pathological dislocation of other site, NEC (disorder) |
Pathological dislocation of joint |
| Pathology specimen submitted (procedure) |
Pathology specimen submitted (situation) |
| Patient assistance |
Assisting |
| Patient died at home |
Died at home |
| Patient died during operation |
Died during operation (finding) |
| Patient died in care home (finding) |
Died in care home |
| Patient died in general practice premises (finding) |
Died in general practice premises (finding) |
| Patient died in hospice (finding) |
Died in hospice |
| Patient died in hospice |
Died in hospice |
| Patient died in hospice |
Died in hospice |
| Patient died in hospital |
Died in hospital |
| Patient died in hospital |
Died in hospital |
| Patient died in nursing home |
Died in nursing home (finding) |
| Patient died in nursing home |
Died in nursing home (finding) |
| Patient died in street |
Died in street (finding) |
| Patient died in street |
Died in street (finding) |
| Patient died in usual place of residence |
Died in usual place of residence |
| Patient held diabetic record declined (finding) |
Provision of patient held diabetes record declined |
| Patient identification band |
Identification band |
| Patient immunocompromised |
Patient immunocompromised |
| Patient immunosuppressed |
patient(e) immunodéprimé(e) |
| Patient immunosuppressed |
patient(e) immunodéprimé(e) |
| Patient immunosuppressed |
patient(e) immunodéprimé(e) |
| Patient refuses hormone replacement therapy (finding) |
Hormone replacement therapy declined |
| patient passé en revu |
Patient review (procedure) |
| Patient reviewed |
Patient review (procedure) |
| Patient reviewed at hospital |
Review at hospital (procedure) |
| Patient reviewed at hospital |
Review at hospital (procedure) |
| Patient written birth plan |
Patient written birth plan (record artifact) |
| Pauciarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Pauciarticular onset juvenile chronic arthritis (disorder) |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Peach - dietary |
Peach (substance) |
| aliment : arachide |
Peanut (substance) |
| Pear - dietary |
Pear (substance) |
| Pectobacterium chrysanthemi (organism) |
Dickeya chrysanthemi |
| Pectoralis major myocutaneous flap plus rib |
Pectoralis major osteomyocutaneous flap of rib |
| Pedicle flap reconstruction - action |
Flap reconstruction - action |
| Pedicle transverse rectus abdominus flap (substance) |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
| Pediculus humanus humanus |
Pediculus humanus |
| Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
| Pegaptanib 0.3mg intravitreal injection solution 1mL prefilled syringe (product) |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
| Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe (product) |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe (product) |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
| Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
| Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen (product) |
Peginterferon alfa-2b only product in parenteral dose form |
| Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen (product) |
Peginterferon alfa-2b only product in parenteral dose form |
| Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial (product) |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial (product) |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial (product) |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial (product) |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen (product) |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
| Pegvisomant 30mg powder for injection solution vial (product) |
Pegvisomant 20 mg powder for solution for injection vial |
| Pelvic somatic dysfunction (finding) |
Somatic dysfunction (finding) |
| Penetrating injury by glass |
Penetrating injury caused by glass fragment |
| Penetrating injury due to glass (disorder) |
Penetrating injury caused by glass fragment |
| Penicillin G benzathine 300,000unit/mL injection (product) |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 1200000unt/2mL suspension (product) |
Product containing only benzylpenicillin (medicinal product) |
| Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial (product) |
Penicillin G benzathine 150000 unit/mL and penicillin G procaine 150000 unit/mL suspension for injection |
| Penicillin g benzathine 300,000unt/mL injection (product) |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection suspension 10mL vial (product) |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection suspension 1mL vial (product) |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 600,000unt/mL injection suspension 1mL vial (product) |
Penicillin G benzathine 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 20mL vial (product) |
Penicillin G benzathine 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 2mL vial (product) |
Penicillin G benzathine 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 4mL vial (product) |
Penicillin G benzathine 600000 unit/mL suspension for injection |
| Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial (product) |
Penicillin G benzathine 900000 unit/mL and penicillin G procaine 300000 unit/mL suspension for injection |
| Penicillin g procaine 600,000unt/mL injection suspension 1mL vial (product) |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g procaine 600,000unt/mL injection suspension 4mL vial (product) |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin overdose |
Penicillin antibacterial overdose (disorder) |
| Penicillin v potassium 500mg (product) |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Penicillin v potassium 500mg tablet (product) |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
FHIR